At Abiomed's European headquarters in Aachen, Germany, Impella heart pumps have been developed and produced for more than 20 years to stabilize and recover the human heart. The single access procedure ...
Large-bore devices and longer time on support each up the risk. A study author calls for awareness, not alarm.
HACKENSACK, N.J., Oct. 28, 2019 /PRNewswire/ -- On October 16, 2019, Hackensack Meridian Health's Hackensack University Medical Center performed its first cardiovascular surgery procedures using a new ...
MERIDIAN, Miss. — Patients in Mississippi previously turned away for heart surgery may have another option in the Impella 2.5, the world's smallest heart pump — now available for elderly, unstable or ...
The Heart Hospital of Northwest Texas Healthcare System has been recognized by Abiomed for its achievement of 200 Impella procedures, according to a news release. This life-changing procedure has ...
Consistent evidence supports benefits of complete revascularization on LVEF, heart failure symptoms DANVERS, Mass.--(BUSINESS WIRE)--Abiomed (Nasdaq: ABMD) announces the results of the Restore EF ...
While no patients have been harmed, the FDA categorized the action as a Class I recall because of the potential for serious ...
There are new and revised warnings about the instructions for use of a certain type of heart pump that could lead to a risk of heart perforation, according to an alert issued by the pump's ...
SAN FRANCISCO (MarketWatch) -- Abiomed Inc. on Monday said that trial data show have show that using its Impella Recover as a left ventricular assist device during high-risk angioplasty/stenting ...
Abiomed (NASDAQ: ABMD) struggled in 2019, but the stock has risen more than 62% so far this year. The question for most investors is how long that trend can continue for the medical device maker.
AACHEN, Germany--(BUSINESS WIRE)--Following consultation with its notified body, MEDCERT GmbH, Abiomed is introducing the single access procedure with Impella CP introducer sheaths for the treatment ...
Shares have risen more than 62% year to date. Is the medical device company still a good buy? Abiomed's devices all have to do with the circulatory system, including the world's smallest heart pump, ...